Tommi Nyrönen

1.8k total citations
36 papers, 814 citations indexed

About

Tommi Nyrönen is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tommi Nyrönen has authored 36 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Computational Theory and Mathematics and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tommi Nyrönen's work include Computational Drug Discovery Methods (7 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Tommi Nyrönen is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Tommi Nyrönen collaborates with scholars based in Finland, United Kingdom and Germany. Tommi Nyrönen's co-authors include Antti Poso, Anu J. Tervo, Mark S. Johnson, Henri Xhaard, Janne T. Backman, Anna‐Marja Hoffrén, Anne M. Filppula, Mikko Niemi, Mika Scheinin and Pertti J. Neuvonen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Chemical Physics Letters.

In The Last Decade

Tommi Nyrönen

36 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tommi Nyrönen Finland 17 420 140 139 102 78 36 814
Nam Sook Kang South Korea 20 526 1.3× 176 1.3× 84 0.6× 70 0.7× 185 2.4× 97 1.2k
Sarah Warburton United States 9 786 1.9× 104 0.7× 40 0.3× 56 0.5× 97 1.2× 10 1.1k
Hui Peng China 23 795 1.9× 203 1.4× 55 0.4× 53 0.5× 170 2.2× 57 1.4k
Danfeng Shi China 21 761 1.8× 220 1.6× 41 0.3× 79 0.8× 155 2.0× 51 1.2k
Irena Melnikova United States 13 367 0.9× 117 0.8× 73 0.5× 48 0.5× 56 0.7× 22 919
Alexander Böcker Germany 14 439 1.0× 131 0.9× 58 0.4× 39 0.4× 59 0.8× 18 736
D. Vidović United States 15 822 2.0× 144 1.0× 67 0.5× 36 0.4× 160 2.1× 28 1.4k
Bianca M. Liederer United States 20 547 1.3× 119 0.8× 52 0.4× 125 1.2× 370 4.7× 44 1.3k
Enrico Guarnera Singapore 21 1.3k 3.1× 462 3.3× 93 0.7× 47 0.5× 61 0.8× 39 1.6k
Nicola Tolliday United States 20 1.6k 3.8× 223 1.6× 117 0.8× 49 0.5× 234 3.0× 28 2.1k

Countries citing papers authored by Tommi Nyrönen

Since Specialization
Citations

This map shows the geographic impact of Tommi Nyrönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommi Nyrönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommi Nyrönen more than expected).

Fields of papers citing papers by Tommi Nyrönen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tommi Nyrönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommi Nyrönen. The network helps show where Tommi Nyrönen may publish in the future.

Co-authorship network of co-authors of Tommi Nyrönen

This figure shows the co-authorship network connecting the top 25 collaborators of Tommi Nyrönen. A scholar is included among the top collaborators of Tommi Nyrönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommi Nyrönen. Tommi Nyrönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristiansson, Kati, E. Katriina Tarkiainen, Liisa Ukkola‐Vuoti, et al.. (2024). Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data. Clinical Pharmacology & Therapeutics. 117(1). 278–288. 1 indexed citations
2.
Thorogood, Adrian, Heidi L. Rehm, Peter Goodhand, et al.. (2021). International federation of genomic medicine databases using GA4GH standards. Cell Genomics. 1(2). 100032–100032. 22 indexed citations
3.
Cabili, Moran N., Jonathan Lawson, Andrea Saltzman, et al.. (2021). Empirical validation of an automated approach to data use oversight. Cell Genomics. 1(2). 100031–100031. 15 indexed citations
4.
Broeder, Daan, et al.. (2018). Federated Identity Management For Research Collaborations. Zenodo (CERN European Organization for Nuclear Research). 6 indexed citations
5.
Brandizi, Marco, Raffael Bild, Florian Kohlmayer, et al.. (2017). Orchestrating differential data access for translational research: a pilot implementation. BMC Medical Informatics and Decision Making. 17(1). 30–30. 6 indexed citations
6.
Tornio, Aleksi, Anne M. Filppula, Mikko Neuvonen, et al.. (2014). Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions. Clinical Pharmacology & Therapeutics. 96(4). 498–507. 114 indexed citations
7.
Via, Allegra, Thomas Blicher, Erik Bongcam‐Rudloff, et al.. (2013). Best practices in bioinformatics training for life scientists. Briefings in Bioinformatics. 14(5). 528–537. 45 indexed citations
8.
Papaioannou, Maria, et al.. (2013). Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives. Anti-Cancer Agents in Medicinal Chemistry. 13(5). 801–810. 10 indexed citations
9.
Schneider, Maria Victoria, James T. Watson, Teresa K. Attwood, et al.. (2010). Bioinformatics training: a review of challenges, actions and support requirements. Briefings in Bioinformatics. 11(6). 544–551. 37 indexed citations
10.
Nyrönen, Tommi, et al.. (2009). Structural basis for computational screening of non-steroidal androgen receptor ligands. Expert Opinion on Drug Discovery. 5(1). 5–20. 2 indexed citations
11.
Xhaard, Henri, Tommi Nyrönen, Jori O. Ruuskanen, et al.. (2005). Model structures of α-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands. Journal of Structural Biology. 150(2). 126–143. 27 indexed citations
12.
Tervo, Anu J., et al.. (2005). BRUTUS:  Optimization of a Grid-Based Similarity Function for Rigid-Body Molecular Superposition. 1. Alignment and Virtual Screening Applications. Journal of Medicinal Chemistry. 48(12). 4076–4086. 34 indexed citations
13.
Tervo, Anu J., et al.. (2004). Comparing the Quality and Predictiveness between 3D QSAR Models Obtained from Manual and Automated Alignment. Journal of Chemical Information and Computer Sciences. 44(3). 807–816. 33 indexed citations
14.
Tervo, Anu J., Sergiy Kyrylenko, Antero Salminen, et al.. (2004). An In Silico Approach to Discovering Novel Inhibitors of Human Sirtuin Type 2. Journal of Medicinal Chemistry. 47(25). 6292–6298. 91 indexed citations
15.
Tervo, Anu J., et al.. (2003). A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods. Journal of Computer-Aided Molecular Design. 17(12). 797–810. 27 indexed citations
16.
Fraunberg, Mikael von und zu, Tommi Nyrönen, & Raili Kauppinen. (2003). Mitochondrial Targeting of Normal and Mutant Protoporphyrinogen Oxidase. Journal of Biological Chemistry. 278(15). 13376–13381. 16 indexed citations
17.
Nyrönen, Tommi, Siegfried Wurster, Marjo Pihlavisto, et al.. (2003). Molecular mechanisms of ligand–receptor interactions in transmembrane domain V of the α2A‐adrenoceptor. British Journal of Pharmacology. 140(2). 347–358. 26 indexed citations
18.
Jouppila, Annukka, Olli T. Pentikäinen, Luca Settimo, et al.. (2002). Determinants of antagonist binding at the α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor subunit, GluR‐D. European Journal of Biochemistry. 269(24). 6261–6270. 6 indexed citations
19.
Nyrönen, Tommi, Marjo Pihlavisto, Anna‐Marja Hoffrén, et al.. (2001). Molecular Mechanism for Agonist-Promoted α2A-Adrenoceptor Activation by Norepinephrine and Epinephrine. Molecular Pharmacology. 59(5). 1343–1354. 53 indexed citations
20.
Salminen, Tiina A., Tommi Nyrönen, Marjo Pihlavisto, et al.. (1999). Three-dimensional Models of α2A-Adrenergic Receptor Complexes Provide a Structural Explanation for Ligand Binding. Journal of Biological Chemistry. 274(33). 23405–23413. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nam Sook Kang Breakdown of academic impact, for papers by Sarah Warburton Breakdown of academic impact, for papers by Hui Peng Breakdown of academic impact, for papers by Danfeng Shi Breakdown of academic impact, for papers by Irena Melnikova Breakdown of academic impact, for papers by Alexander Böcker Breakdown of academic impact, for papers by D. Vidović Breakdown of academic impact, for papers by Bianca M. Liederer Breakdown of academic impact, for papers by Enrico Guarnera Breakdown of academic impact, for papers by Nicola Tolliday
Rankless by CCL
2026